Medical biotechnology in India.
The potential of biotechnology has just began to emerge in the 20th century. After the full knowledge of human genomes is available, biotechnology is going to play a major role in shaping the concept of future drug discovery, drug delivery, diagnostic methodology, clinical trials, and to a great extent the major lifestyle of the human society. This article is a comprehensive review of the major impact of biotechnology in diagnostics, antibiotics, r-proteins, vaccines, and antibodies production. It also highlights the future aspects of gene therapy in the management of healthcare. A comprehensive list of biotech products in healthcare management has been given. Also, the growth of biotechnology throughout the world at large and in the Indian industries in particular has been highlighted. Constraints, concerns and difficulties in biotechnology in India have been addressed mainly related to human resources, training institutions in India, funding in biotechnology, patent-related issues and regulatory hurdles. Like in information technology, India has great potential in bioinformatics as well. Some of the recent information on bioinformatics centers in India has been summarized. Indian biotechnology industries have the potential to use the modern discoveries in life sciences to reach an enviable position in the world of biotechnology.
Lohray
Braj B
BB
Zydus Research Center, Cadila Healthcare Ltd., Sarkhej-Bavla Highway, Moraiya, Ahmedabad-382 213, India. braj.lohray@zyduscadila.com
D000906:Antibodies; D020811:Biomedical Technology; D001709:Biotechnology / Q000191:economics / Q000379:methods* / Q000639:trends*; D019295:Computational Biology / Q000379:methods / Q000639:trends; D015195:Drug Design; D004345:Drug Industry / Q000191:economics / Q000379:methods* / Q000639:trends*; D015316:Genetic Therapy / Q000379:methods / Q000639:trends; D006801:Humans; D016233:Immunotherapy, Active / Q000379:methods / Q000639:trends; D007194:India; D020411:Oligonucleotide Array Sequence Analysis / Q000295:instrumentation / Q000639:trends; D011506:Proteins / Q000627:therapeutic use; D011933:Reagent Kits, Diagnostic; D011994:Recombinant Proteins / Q000627:therapeutic use; D014612:Vaccines / Q000138:chemical synthesis / Q000627:therapeutic use
D000906:Antibodies; D011506:Proteins; D011933:Reagent Kits, Diagnostic; D011994:Recombinant Proteins; D014612:Vaccines